Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis (Q36507323)

14 August 2017

1 reference

title

Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis (English)

1 reference

14 August 2017

Judith E Raber-Durlacher

6

object named as

Judith E Raber-Durlacher

1 reference

14 August 2017

Inger von Bültzingslöwen

1

1 reference

14 August 2017

Michael T Brennan

2

1 reference

14 August 2017

Fred K L Spijkervet

3

1 reference

14 August 2017

Richard Logan

4

1 reference

14 August 2017

Andrea Stringer

5

1 reference

14 August 2017

Dorothy Keefe

7

1 reference

14 August 2017

21 April 2006

1 reference

Supportive Care in Cancer

14 August 2017

1 reference

14 August 2017

14

1 reference

14 August 2017

6

1 reference

14 August 2017

519-527

1 reference

https://scigraph.springernature.com/pub.10.1007/s00520-006-0052-7

14 August 2017

0 references

cites work

Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00520-006-0052-7

Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: a prospective randomized study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00520-006-0052-7

Granulocyte macrophage-colony-stimulating factor mouthwashes heal oral ulcers during head and neck radiotherapy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00520-006-0052-7

Keratinocytes and cytokine/growth factors

21 January 2018

1 reference

12 December 2020

Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study

1 reference

12 December 2020

Treatment of irradiation-induced mucositis with growth factors (rhGM-CSF) in patients with head and neck cancer.

1 reference

12 December 2020

Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality

1 reference

12 December 2020

Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation

1 reference

12 December 2020

Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis

1 reference

12 December 2020

Hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and mitomycin-C (+/- granulocyte-colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma

1 reference

12 December 2020

Milk growth factors enriched from cheese whey ameliorate intestinal damage by methotrexate when administered orally to rats

1 reference

12 December 2020

Lactoferrin reduces methotrexate-induced small intestinal damage, possibly through inhibition of GLP-2-mediated epithelial cell proliferation

1 reference

12 December 2020

Rating the quality of evidence for clinical practice guidelines

1 reference

12 December 2020

Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, ran

1 reference

12 December 2020

Topical transforming growth factor-beta3 in the prevention or alleviation of chemotherapy-induced oral mucositis in patients with lymphomas or solid tumors

1 reference

12 December 2020

Kinetics of Epidermal Growth Factor in Saliva

1 reference

12 December 2020

Granulocyte-macrophage colony-stimulating factor mouthwashes improve radiation induced mucositis in AIDS patients

1 reference

12 December 2020

IL-11, a pleiotropic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biology

1 reference

12 December 2020

Dietary supplementation with zinc and a growth factor extract derived from bovine cheese whey improves methotrexate-damaged rat intestine

1 reference

12 December 2020

A pilot study of the effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during X-radiation therapy: a preliminary report

1 reference

12 December 2020

Oral RDP58 allows CPT-11 dose intensification for enhanced tumor response by decreasing gastrointestinal toxicity

1 reference

12 December 2020

Phase I study of transforming growth factor-beta3 mouthwashes for prevention of chemotherapy-induced mucositis.

1 reference

12 December 2020

GM-CSF mouthrinses in the treatment of severe oral mucositis: a pilot study

1 reference

12 December 2020

Exposure of oral mucosa to bioactive milk factors reduces severity of chemotherapy-induced mucositis in the hamster.

1 reference

12 December 2020

Clinical development of recombinant human interleukin-11 to treat chemotherapy-induced thrombocytopenia

1 reference

12 December 2020

Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF): an appraisal of its pharmacoeconomic status in neutropenia associated with chemotherapy and autologous bone marrow transplant

1 reference

12 December 2020

Teduglutide ([Gly2]GLP-2) protects small intestinal stem cells from radiation damage

1 reference

12 December 2020

Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositis

1 reference

12 December 2020

Assessment of epidermal growth factor in oral secretions of patients receiving radiation therapy for cancer

1 reference

12 December 2020

A phase Ib clinical trial of PV701, a milk-derived protein extract, for the prevention and treatment of oral mucositis in patients undergoing high-dose BEAM chemotherapy

1 reference

12 December 2020

Keratinocyte growth factor: a unique player in epithelial repair processes

1 reference

12 December 2020

Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis after hematopoietic stem-cell transplantation

1 reference

12 December 2020

Reduction of oral mucositis by filgrastim (r-metHuG-CSF) in patients receiving chemotherapy

1 reference

12 December 2020

Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs

1 reference

12 December 2020

Hemopoietins in clinical oncology

1 reference

12 December 2020

Effect of granulocyte-macrophage colony-stimulating factor on prevention of mucositis in head and neck cancer patients treated with chemo-radiotherapy

1 reference

12 December 2020

Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trial

1 reference

12 December 2020

The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy

1 reference

12 December 2020

A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation.

1 reference

12 December 2020

Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash

1 reference

12 December 2020

Preclinical characterization of CG53135 (FGF-20) in radiation and concomitant chemotherapy/radiation-induced oral mucositis.

1 reference

12 December 2020

Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats

1 reference

12 December 2020

Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters

1 reference

12 December 2020

Subcutaneous granulocyte-macrophage colony-stimulating factor in mucositis induced by an adjuvant 5-fluorouracil plus leucovorin regimen. A phase II study and review of the literature.

1 reference

12 December 2020

In vitro and in vivo effects of repifermin (keratinocyte growth factor-2, KGF-2) on human carcinoma cells

1 reference

12 December 2020

The effects of keratinocyte growth factor in preclinical models of mucositis

1 reference

12 December 2020

Effect of locally applied GM-CSF on oral mucositis after stem cell transplantation: a prospective placebo-controlled double-blind study

1 reference

12 December 2020

Studies of oral neutrophil levels in patients receiving G‐CSF after autologous marrow transplantation

1 reference

12 December 2020

Relationship of oral complications to peripheral blood leukocyte and platelet counts in patients receiving cancer chemotherapy

1 reference

12 December 2020

Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients

1 reference

12 December 2020

Chemotherapy-induced oral mucositis. Prevention and management

1 reference

12 December 2020

Use of granulocyte colony stimulating factor to reduce the toxicity of super-VAC chemotherapy in advanced solid tumours in childhood.

1 reference

12 December 2020

Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis

1 reference

12 December 2020

Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue

1 reference

12 December 2020

The effect of keratinocyte growth factor on healing of manifest radiation ulcers in mouse tongue epithelium

1 reference

12 December 2020

Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy

1 reference

12 December 2020

Pre-treatment with insulin-like growth factor-I partially ameliorates 5-fluorouracil-induced intestinal mucositis in rats

1 reference

12 December 2020

The effect of keratinocyte growth factor on tumour growth and small intestinal mucositis after chemotherapy in the rat with breast cancer

1 reference

12 December 2020

Palifermin reduces diarrhea and increases survival following irinotecan treatment in tumor-bearing DA rats.

1 reference

12 December 2020

The effect of granulocyte colony-stimulating factor on oral mucositis in head and neck cancer patients treated with hyperfractionated radiotherapy

1 reference

12 December 2020

Randomized Phase I Trial of Recombinant Human Keratinocyte Growth Factor Plus Chemotherapy: Potential Role as Mucosal Protectant

1 reference

12 December 2020

Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutropenic cancer patients

1 reference

12 December 2020

Salivary epidermal growth factor levels decrease in patients receiving radiation therapy to the head and neck

1 reference

12 December 2020

Mouth-washings with recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) do not improve grade III-IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Results of a

1 reference

12 December 2020

Amelioration of acute oral mucositis by keratinocyte growth factor: fractionated irradiation

1 reference

12 December 2020

Palifermin for oral mucositis after intensive therapy for hematologic cancers

1 reference

12 December 2020

Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma

1 reference

12 December 2020

10.1007/S00520-006-0052-7

Identifiers

DOI

1 reference

14 August 2017

1 reference